Chen Hui-Ming, Hsu Chung-Yuan, Pan Bo-Lin, Huang Chih-Fang, Chen Chao-Tung, Chuang Hung-Yi, Lee Chih-Hung
Department of Family Medicine and Occupational Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833401, Taiwan.
Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833401, Taiwan.
J Endocr Soc. 2024 Mar 5;8(5):bvae035. doi: 10.1210/jendso/bvae035. eCollection 2024 Mar 12.
This study aimed to determine if a combination of 2 abnormal lipid profiles revealed a stronger association with low bone mass than a single blood lipid abnormality alone.
This study enrolled 1373 participants who had received a dual-energy x-ray absorptiometry scan from January 2016 to December 2016 in a medical center in southern Taiwan. Logistic regression was used to examine association between lipid profiles and osteopenia or osteoporosis after adjusting for covariates.
Compared to people with total cholesterol (TC) < 200 mg/dL, those with TC ≥ 240 mg/dL tended to have osteopenia or osteoporosis (OR 2.61; 95% CI, 1.44-4.71). Compared to people with low-density lipoprotein cholesterol (LDL-C) < 130 mg/dL, those with LDL-C ≥ 160 mg/dL tended to develop osteopenia or osteoporosis (OR 2.13; 95% CI, 1.21-3.74). The association of increased triglyceride and decreased bone mass was similar, although not statistically significant. Those with the combination of TG ≥ 200 mg/dL and TC ≥ 240 mg/dL had a stronger tendency to have osteopenia or osteoporosis (OR 3.51; 95% CI, 1.11-11.13) than people with only one blood lipid abnormality. Similarly, people with TG ≥ 200 mg/dL and LDL-C ≥ 160 mg/dL had a stronger tendency to have osteopenia or osteoporosis (OR 9.31; 95% CI, 1.15-75.42) than people with only one blood lipid abnormality, after adjustment for the same covariates.
Blood levels of TC, LDL-C, and TG were associated with osteopenia or osteoporosis. Results indicate that individuals aged older than 50 years with abnormal lipid profiles should be urged to participate in a bone density survey to exclude osteopenia or osteoporosis.
本研究旨在确定与单一血脂异常相比,两种异常血脂谱组合是否与低骨量有更强的关联。
本研究纳入了2016年1月至2016年12月在台湾南部一家医疗中心接受双能X线吸收测定扫描的1373名参与者。在调整协变量后,使用逻辑回归分析来检验血脂谱与骨质减少或骨质疏松之间的关联。
与总胆固醇(TC)<200mg/dL的人相比,TC≥240mg/dL的人更易出现骨质减少或骨质疏松(比值比[OR]2.61;95%置信区间[CI]:1.44 - 4.71)。与低密度脂蛋白胆固醇(LDL - C)<130mg/dL的人相比,LDL - C≥160mg/dL的人更易发生骨质减少或骨质疏松(OR 2.13;95%CI:1.21 - 3.74)。甘油三酯升高与骨量降低的关联类似,尽管无统计学显著意义。与仅有一项血脂异常的人相比,甘油三酯(TG)≥200mg/dL且TC≥240mg/dL的人更易出现骨质减少或骨质疏松(OR 3.51;95%CI:1.11 - 11.13)。同样,在调整相同协变量后,与仅有一项血脂异常的人相比,TG≥200mg/dL且LDL - C≥160mg/dL的人更易出现骨质减少或骨质疏松(OR 9.31;95%CI:1.15 - 75.42)。
TC、LDL - C和TG的血液水平与骨质减少或骨质疏松相关。结果表明,应敦促50岁以上血脂谱异常的个体参加骨密度检查以排除骨质减少或骨质疏松。